首页 | 本学科首页   官方微博 | 高级检索  
     


Prohibitin expression is associated with high grade breast cancer but is not a driver of amplification at 17q21.33
Authors:Lucy R. Webster  Pamela J. Provan  Dinny J. Graham  Karen Byth  Robert L. Walker  Sean Davis  Elizabeth L. Salisbury  Adrienne L. Morey  Robyn L. Ward  Nicholas J. Hawkins  Christine L. Clarke  Paul S. Meltzer  Rosemary L. Balleine
Affiliation:2. Westmead Institute for Cancer Research, Westmead, Australia;3. Westmead Millennium Institute, Westmead, Australia;4. Tissue Pathology, Institute of Clinical Pathology and Medical Research, Westmead Hospital, Westmead, Australia;6. Translational Oncology, Sydney West Cancer Network, Western Sydney and Nepean Blue Mountains Local Health Districts, Westmead, Australia;5. Anatomical Pathology, St Vincent’s Hospital, Darlinghurst, Australia;11. School of Medical Sciences University of New South Wales, Randwick, Australia;12. School of Biomedical Sciences, Charles Sturt University, Wagga Wagga, New South Wales, Australia;8. Genetics Branch, National Cancer Institute, Bethesda MD USA
Abstract:
Keywords:Breast cancer  genomic amplification  grade  prohibitin
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号